These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 20621392)
1. Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit. Levy SS; Mello MJ; Gusmão-Filho FA; Correia JB J Hosp Infect; 2010 Sep; 76(1):66-9. PubMed ID: 20621392 [TBL] [Abstract][Full Text] [Related]
2. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study. Demir S; Soysal A; Bakir M; Kaufmann ME; Yagci A J Paediatr Child Health; 2008 Oct; 44(10):548-53. PubMed ID: 18557808 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London. Skippen I; Shemko M; Turton J; Kaufmann ME; Palmer C; Shetty N J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810 [TBL] [Abstract][Full Text] [Related]
6. A case-control study of risk factors associated with rectal colonization of extended-spectrum beta-lactamase producing Klebsiella sp. in newborn infants. Boo NY; Ng SF; Lim VK J Hosp Infect; 2005 Sep; 61(1):68-74. PubMed ID: 15953660 [TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Bagattini M; Crivaro V; Di Popolo A; Gentile F; Scarcella A; Triassi M; Villari P; Zarrilli R J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430 [TBL] [Abstract][Full Text] [Related]
8. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital. Basak S; Mallick SK; Bose S J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468 [TBL] [Abstract][Full Text] [Related]
9. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822 [TBL] [Abstract][Full Text] [Related]
10. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Wener KM; Schechner V; Gold HS; Wright SB; Carmeli Y Antimicrob Agents Chemother; 2010 May; 54(5):2010-6. PubMed ID: 20211888 [TBL] [Abstract][Full Text] [Related]
11. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919 [TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome. Panhotra BR; Saxena AK; Al-Ghamdi AM Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248 [TBL] [Abstract][Full Text] [Related]
14. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population. Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004 [TBL] [Abstract][Full Text] [Related]
15. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study. Behar PR; Teixeira PJ; Fachel JM; Kalil AC J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077 [TBL] [Abstract][Full Text] [Related]
16. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns. Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. Papadimitriou-Olivgeris M; Marangos M; Fligou F; Christofidou M; Bartzavali C; Anastassiou ED; Filos KS J Antimicrob Chemother; 2012 Dec; 67(12):2976-81. PubMed ID: 22927316 [TBL] [Abstract][Full Text] [Related]